Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection

J Clin Apher. 1995;10(4):188-93. doi: 10.1002/jca.2920100406.

Abstract

Fifteen patients with prolonged neutropenia (a median of 23 days with granulocyte [PMN] < or = 500/microliters) and established fungal infections that had not responded to adequate antifungal therapy were transfused with PMN concentrates collected from 35 cytokine-primed granulocyte colony-stimulating factor (GCSF) donors. Patients received a median of six transfusions. Leukocytosis and granulocytosis were observed within 24 hours of the first GCSF injection, which yielded concentrates averaging 55 x 10(9) white blood cells and 41 x 10(9) PMN. Data analysis suggested that response might be related to the duration of neutropenia and known infection, as patients given PMN tx earlier in the infectious course tended to have a better response. No significant toxicity was observed in donors.

MeSH terms

  • Blood Component Transfusion*
  • Blood Donors*
  • Blood Specimen Collection / methods*
  • Bone Marrow Diseases / etiology
  • Bone Marrow Diseases / therapy*
  • Female
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Granulocytes / drug effects
  • Granulocytes / transplantation*
  • Humans
  • Leukocyte Count / drug effects
  • Male
  • Mycoses / complications*
  • Neutropenia / etiology
  • Neutropenia / therapy*
  • Treatment Outcome

Substances

  • Granulocyte Colony-Stimulating Factor